Abstract
The “sphingolipidoses” constitute a group of heritable diseases involving storage of various glycosphingolipids mainly in the central nervous system.1 There are two major types of neural glycosphingolipids; cerebroside and its sulfate ester, sulfatide, are characteristic of white matter, and gangliosides are characteristic of gray matter. Storage of cerebrosides are found in Gaucher’s disease (glycosylceramide),2 Fabry’s disease (galactosylgalactosylglucosylceramide),3 Krabbe’s disease (galactosylceramide),4 lactosylceramide lipidosis,5 metachromatic leukodystrophy (galactosyl-3-sulfate ceramide),6 Niemann-Pick disease (phosphorylcholine ester of ceramide),7 and fucosidosis (tetra- and pentahexoside ceramide).8 There are six known gangliosidoses. Three of these, Tay-Sachs disease (TSD),9 late infantile lipidosis,10,11 and Sandhoff’s disease12 involve mainly storage of the GM2-ganglioside in brain tissue. Two others, Norman-Landing disease,13 or general gangliosidosis,14 and Derry’s disease,15 or juvenile gangliosidosis,14 result in an accumulation of the GM1-ganglioside in brain and other tissues. A disorder of ganglioside metabolism with storage of both GM2- and GM3-gangliosides has been reported in a single patient by Pilz et al.16
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stoffel, W., Sphingolipids, Annu. Rev. Biochem. 40: 57 (1971).
Fredrickson, D. S. and Sloan, H. R., Glucosylceramide lipidoses. Gaucher’s disease, in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 730–759 (1972).
Sweeley, C. C., Klionsky, B., Krivit, W., and Desnick, R. J., Fabry’s disease. Glycosphingolipid lipidosis, in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 663–687 (1972).
Suzuki, K. and Suzuki, Y., Galactosyl ceramide lipidosis: Globoid cell leucodystrophy (Krabbe’s disease), in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 760–782 (1972).
Dawson, G., Matalon, R., and Stein, A. O., Lactosylceramidosis: Lactosylceramide galactosyl hydrolase deficiency and accumulation of lactosylceramide in cultured skin fibroblasts, J. Pediatr. 79: 423 (1971).
Moser, H. W., Sulfatide lipidoses: Metachromatic leukodystrophy, in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 688–729 (1972).
Fredrickson, D. S. and Sloan, H. R., Sphingomyelin lipidoses: Niemann-Pick disease, in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 783–807 (1972).
Durand, P., Barrone, C., Delia Cella, G., and Philippart, M., Fucosidosis, Lancet 1: 1198 (1968).
Volk, B. W., Schneck, L., and Adachi, M., Clinic pathology and biochemistry of Tay-Sachs disease, in: Handbook of Clinical Neurology, P. J. Vinken, and G. W. Bruyn, eds., North-Holland, Amsterdam, Vol. 10, pp. 385–426 (1970).
Bernheimer, H. and Seiteiberger, F.: Über das Verhalten der Ganglioside im Gehirn bei 2 Fällen von spatinfantiler amaurotischer Idiotie. Wien Klin. Wochenschr. 80: 163 (1968).
Volk, B. W., Adachi, M., Schneck, L., Saifer, A., and Kleinberg, W., G-5 variant of systemic late infantile lipidosis, Arch. Pathol. 87: 393 (1969).
Sandhoff, K., Andreae, U., and Jatzkewitz, H., Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs, Life Sci. 7: 283 (1968).
Landing, B. H., Silverman, F. N., Craig, M. M., Jacoby, M. D., Lahey, M. E., and Chadwick, D. L., Familial neurovisceral lipidosis, Am. J. Dis. Child. 108: 503 (1964).
O’Brien, J. S., GM1-gangliosidoses, in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 639–662 (1972).
Derry, D. M., Fawcett, J. S., Andermann, F., and Wolfe, L. S., Late infantile systemic lipidosis. Major monosialogangliosidosis, delineation of two types, Neurology 18: 340 (1968).
Pilz, H., Müller, D., Sandhoff, K., and ter Meulen, V., Tay-Sachssche Krankheit mit Hexosaminidase-Defekt. Klinische, morphologische und biochemische Befunde bei einem Fall mit viszeraler Speicherung von Nierenglobosid, Dtsch. Med. Wochenschr. 39: 1833 (1968).
Klenk, E., The pathological chemistry of the developing brain, in: Biochemistry of the Developing Nervous System, E. Waeisch, ed., Academic Press, New York, pp. 397–409 (1955).
Svennerholm, L., The nature of the gangliosides in Tay-Sachs disease, in: Cerebral Lipidosis, L. van Bogaert, J. N. Cumings, and A. Lowenthal, eds., Blackwell, Oxford, pp. 139–145 (1957).
Saifer, A. and Wishnow, D. E., Disturbances of lipid metabolism and their relationship to the lipidoses, in: Handbook of Clinical Neurology, P. J. Vinken, and G. W. Bruyn, eds., North-Holland, Amsterdam, Vol. 10, pp. 265–324 (1970).
King, J., Practical Clinical Enzymology, Van Nostrand, Princeton, N. J. (1965).
Svennerholm, L., The chemical structure of normal human brain and Tay-Sachs gangliosides, Biochem. Biophys. Res. Commun. 9: 436 (1962).
Svennerholm, L., Chromatographic separation of human brain gangliosides, J. Neurochem. 10: 613 (1963).
Saifer, A., The biochemistry of Tay-Sachs disease, in: Tay-Sachs Disease, B. W. Volk, ed., Grüne & Stratton, New York, pp. 97–103 (1964).
Aronson, S. M., Saifer, A., Perle, G., and Volk, B. W., Studies on enzyme alterations in the infantile sphingolipidoses. Correlation with pathologic changes, Am. J. Clin. Nutr. 9: 103 (1961).
Aronson, S. M., Saifer, A., Kanof, A., and Volk, B. W., Progression of amaurotic family idiocy as reflected by serum and cerebrospinal fluid changes, Am. J. Med. 24: 390 (1958).
Siegel, A. and Bing, R. J., Plasma enzyme activity in myocardial infarction in dog and man, Proc. Soc. Exp. Biol. Med. 91: 604 (1956).
Saifer, A., Schneck, L., Perle, G., and Volk, B. W., Lactate dehydrogenase isoenzyme distribution in the cerebral sphingolipidoses and other neurological disorders, Neurology 19: 147 (1969).
Aronson, S. M., Perle, G., Saifer, A., and Volk, B. W., Biochemical identification of the carrier state in Tay-Sachs disease, Proc. Soc. Exp. Biol. Med. 111: 664 (1962).
Schneck, L., Perle, G., and Volk, B. W., Fructose tolerance in Tay-Sachs’ disease, Pediatrics 36: 272 (1965).
Klenk, E., Beiträge zur Chemie der Lipoidosen, Niemann-Pick’sche Krankheit und amaurotische Idiotie, Hoppe-Seyler’s Z. Physiol. Chem. 262: 128 (1939–1940).
Klenk, E., Über die Ganglioside des Gehirns bei der infantilen amaurotischen Idiotie von Typus Tay-Sachs, Ber. Dtsch. Chem. Ges. 75: 1632 (1942).
Svennerholm, L., The gangliosides, J. Lipid Res. 5: 145 (1964).
Gatt, S. and Berman, E. R., Studies on brain lipids in Tay-Sachs disease. I. Isolation of two sialic acid-free glycolipids, Neurochem. 10: 43 (1963).
Suzuki, K., Ganglioside patterns of normal and pathological brain, in: Inborn Disorders of Sphingolipid Metabolism, S. M. Aronson, and B. W. Volk, eds., Pergamon Press, New York, pp. 215–230 (1967).
Klenk, E., Liedtke, U., and Gielen, W., Das Gangliosid des Gehirns bei der infantilen amaurotischen Idiotie vom Typ Tay-Sachs, Hoppe-Seyler’s Z. Physiol. Chem. 334: 186 (1963).
Makita, A. and Yamakawa, T., The glycolipids of the brain of Tay-Sachs disease. The chemical structures of a globoside and main ganglioside, Jpn. J. Exp. Med. 33: 361 (1963).
Ledeen, R., The chemistry of gangliosides: A review, J. Am. Oil Chem. Soc. 43: 57 (1966).
Wiegandt, H., Ganglioside, Ergeh. Physiol. Biol. Chem. Exp. Pharmakol. 57: 190 (1966).
Volk, B. W., ed., Tay-Sachs’ Disease, Grune & Stratton, New York, (1964).
Stanbury, J. B., Wyngaarden, J. B., and Fredrickson, D. S., eds., The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, Chaps. 1 and 2 (1972).
Suzuki, K., Suzuki, K., and Kamoshita, S., Chemical pathology of GM1-gangliosidosis (generalzied gangliosidosis), J. Neuropathol. Exp. Neurol. 28: 25 (1969).
Kolodny, E. H., Brady, R. O., and Volk, B. W., Demonstration of an alteration of ganglioside metabolism in Tay-Sachs disease, Biochem. Biophys. Res. Commun. 37: 526 (1969).
Okada, S. and O’Brien, J., Tay-Sachs disease: Generalized absence of a β-D-N-acetylhexosaminidase component, Science 165: 698 (1969).
Robinson, D. and Stirling, J. L., N-Acetyl-β-glucosaminidases in human spleen, Biochem. J. 107: 321 (1968).
Sandhoff, K., Variation of β-N-acetylhexosaminidase-pattern in Tay-Sachs disease, FEBS Lett. 4: 351 (1969).
Hultberg, B., N-acetylhexosaminidase activities in Tay-Sachs disease, Lancet 2: 1195 (1969).
Helferich, B. and Iloff, A., Über Emulsion. XIII. Darstellung und fermentative Spaltung von Glykosiden des N-Acetyl-glucosamins und der 2-Desoxyglucose, Hoppe-Seyler’s Z. Physiol. Chem. 221: 252 (1933).
Caygill, J. C. and Jevons, F. R., β-Glucosaminidase activity in human synovial fluid, blood, plasma and leucocytes, Clin. Chim. Acta 13: 61 (1966).
Furiya, S. and Fukuda, A., Estimation of serum β-acetylaminodeoxyglucosidase, J. Biochem. 54: 398 (1963).
Leaback, D. H. and Walker, P. G., Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-β-glucosaminidase, Biochem. J. 78: 151 (1961).
Woollen, J. W. and Turner, P., Plasma N-acetyl-β-glucosaminidase and β-glucuronidase in health and disease, Clin. Chim. Acta 12: 671 (1965).
Price, R. G., Dance, N., Richards, B., and Cattell, W. R., The excretion of N-acetyl-β-glucosaminidase and β-galactosidase following surgery to the kidney, Clin. Chim. Acta 27: 65 (1970).
Sandman, R., Margules, R. M. and Kountz, S. L., Urinary lysosomal glycosidases after renal allotransplantation: Correlation of enzyme excretion with allograft rejection and ischemia, Clin. Chim. Acta 45: 349 (1973).
Walker, P. G., Woollen, J. W., and Heyworth, R., Studies on glucosaminidase. 5. Kidney N-acetyl-β-glucosaminidase and N-acetyl-β-galactosaminidase, Biochem. J. 79: 288 (1961).
Li, S.-C. and Li, Y.-T., Studies on the glycosidases of Jack Bean meal. 3. Crystallization and properties of β-N-acetylhexosaminidase, J. Biol. Chem. 245: 5153 (1970).
Mega, T., Ikenaka, T., and Matsushima, Y., Studies on N-acetyl-β-D-glucosaminidase of Aspergillus oryzae, J. Biochem. 68: 109 (1970).
Frohwein, Y. Z. and Gatt, S., Isolation of β-N-acetylhexosaminidase, β-N-acetylglu- cosaminidase, and β-N-acetylgalactosaminidase from calf brain, Biochemistry 6: 2775 (1967).
Wetmore, S. J. and Verpoorte, J. A., The partial purification of two β-N-acetyl-D-hexosaminidases from porcine kidney, Can. J. Biochem. 50: 563 (1972).
Verpoorte, J. A., Purification of two β-N-acetyl-D-glucosaminidases from beef spleen, J. Biol. Chem. 241: 4m (1972).
Sandhoff, K. and Wassle, W., Anreicherung und Charakterisierung zweier Formen der menschlichen N-acetyl-β-D-hexosaminidase, Hoppe-Seyler’s Z. Physiol. Chem. 352: 1119 (1971).
Li, Y.-T., Mazzotta, M. Y., Wan, C.-C., Orth, R., and Li, S.-C., Hydrolysis of Tay-Sachs ganglioside by β-hexosaminidase A of human liver and urine, J. Biol. Chem. 248: 7512 (1973).
Carroll, M. and Robinson, D., Immunological properties of N-acetyl-β-D-glucosaminidase of normal human liver and of GM2-gangliosidosis liver, Biochem. J. 131: 91 (1973).
Verpoorte, J. A., Isolation and characterization of the major β-N-acetyl-D-glucosaminidase from human plasma, Biochemistry 13: 793 (1974).
Srivastava, S. K., Awasthi, Y. C., Yoshida, A., and Beutler, E., Studies on human (β-D-N-acety Hexosaminidases. I. Purification and properties, J. Biol. Chem. 249: 2043 (1974).
Goldstone, A., Konecny, P., and Koenig, H., Lysosomal hydrolases: Conversion of acidic to basic forms by neuraminidase, FEBS Lett. 13: 68 (1971).
Murphy, J. V. and Craig, L., Neuraminidase-induced changes in white blood cell hexosaminidase A, Clin. Chim. Acta 42: 267 (1972).
Srivastava, S. K., Yoshida, A., Awasthi, Y. C., and Beutler, E., Studies on human β-D-N-acety Hexosaminidases. II. Kinetic and structural properties, J. Biol. Chem. 249: 2049 (1974).
van Someren, H. and van Henegouwen, H. B., Independent loss of human hexosaminidases A and B in man-Chinese hamster somatic cell hybrids, Humangenetik 18: 171 (1973).
Dawson, G., Propper, R. L., and Dorfman, A., Partial purification of β-N-acetylhexosaminidase A by affinity chromatography, Biochem. Biophys. Res. Commun. 54: 1102 (1973).
Grebner, E. E. and Parikh, I., An affinity adsorbent for N-acetyl-β-hexosaminidase A, Biochim. Biophys. Acta 350: 437 (1974).
Grebner, E. E. and Tucker, J., Human urinary N-acetyl-β-hexosaminidases, Biochim. Biophys. Acta 321: 228 (1973).
Srivastava, S. K. and Beutler, E., Antibody against purified human hexosaminidase B cross-reacting with hexosaminidase A, Biochem. Biophys. Res. Commun. 47: 753 (1972).
Robinson, D., and Carroll, M., Tay-Sachs disease: Interrelation of hexosaminidases A and B, Lancet 1: 322 (1972).
Price, R. G. and Dance, N., The demonstration of multiple heat-stable forms of N-acetyl-β-glucosaminidase in normal human serum, Biochim. Biophys. Acta 271: 145 (1972).
Srivastava, S. K. and Beutler, E., Studies on human β-D-N-acety Hexosaminidases. III. Biochemical genetics of Tay-Sachs and Sandhoff’s diseases, J. Biol. Chem. 249: 2054 (1974).
Srivastava, S. K., and Beutler, E., Hexosaminidase-A and hexosaminidase-B: Studies in Tay-Sachs and Sandhoff’s disease, Nature (London) 241: 463 (1973).
Ford, J. R., Nunley, J. A., Li, Y.-T., Chambers, R. P., and Cohen, W., A continuously monitored spectrophotometric assay of glycosidases with nitrophenyl glycosides, Anal. Biochem. 54: 120 (1973).
Rosenthal, A. L. and Saifer, A., Continuous UV monitoring of fluorogenic substrates. I. Kinetic analysis of N-acetyl-β-D-hexosaminidases, Anal. Biochem. 55: 85 (1973).
Kanfer, J. N. and Spielvogel, C. H., The inhibition of β-N-acetylhexosaminidases by lactones, Biochim. Biophys. Acta 327: 405 (1973).
Sandhoff, K., Andreae, U., and Jatzkewitz, H., Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs, Pathol. Eur. 3: 278 (1968).
Frohwein, Y. Z. and Gatt, S., Enzymatic hydrolysis of sphingolipids. VI. Hydrolysis of ceramide glycosides by calf brain β-N-acetylhexosaminidase, Biochemistry 6: 2783 (1967).
Dance, N., Price, R. G., Robinson, D., and Stirling, J. L., β-Galactosidase, β-glucosidase and N-acetyl-β-glucosaminidase in human kidney, Clin. Chim. Acta 24: 189 (1969).
Robinson, D., Price, R. G., and Dance, N., Separation and properties of β-galactosidase, β-glucosidase, β-glucuronidase and N-acetyl-β-glucosaminidase from rat kidney, Biochem. J. 102: 525 (1967).
Young, E. P., Ellis, R. B., Lake, B. D., and Patrick, A. D., Tay-Sachs disease and related disorders: Fractionation of brain N-acetyl-β-hexosaminidase on DEAE-cellulose, FEBS Lett. 9: 1 (1970).
Robinson, D., Jordan, T. W., and Horsburgh, T., The N-acetyl-β-D-hexosaminidases of calf and human brain, J. Neurochem. 19: 1975 (1972).
Hooghwinkel, G. J. M., Veltkamp, W. A., Overdijk, B., and Lisman, J. J. W., Electrophoretic separation of β-N-acetylhexosaminidases of human and bovine brain and liver and of Tay-Sachs brain tissue, Hoppe-Seyler’s Z. Physiol. Chem. 353: 839 (1972).
Poenaru, L. and Dreyfus, J. C., Electrophoretic study of hexosaminidases. Hexosaminidase C, Clin. Chim. Acta 43: 439 (1973).
Hultberg, B. and Ockerman, P. A., Artificial substrates in the assay of acid glycosidases, Clin. Chim. Acta 39: 49 (1972).
Hultberg, B., Ockerman, P. A., and Norden, N. E., Isoenzymes of four acid hydrolases in human kidney and urine, Clin. Chim. Acta 52: 239 (1974).
Kanfer, J. N. and Spielvogel, C., Hexosaminidase activity of cultured human skin fibroblasts, Biochim. Biophys. Acta 293: 203 (1973).
Okada, S., Veath, M. L., Leroy, J., and O’Brien, J. S., Ganglioside GM2 storage diseases: Hexosaminidase deficiencies in cultured fibroblasts, Am. J. Hum. Genet. 23: 55 (1971).
Woolen, J. and Walker, P. G., The fluorimetric estimation of N-acetyl-β-glucosamini- dase and β-galactosidase in blood plasma, Clin. Chim. Acta 12: 647 (1965).
Stirling, J. L., A new form of N-acetyl-β-glucosaminidase present in pregnancy serum, Biochem. J. 123: 11P (1971).
O’Brien, J. S., Okada, S., Chen, A., and Fillerup, D. L., Tay-Sachs disease: Detection of heterozygotes and homozygotes by serum hexosaminidase assay, New Engl. J. Med. 283: 15 (1970).
Walker, P. G., Woollen, M. E., and Pugh, D., N-Acetyl-β-glucosaminidase activity in serum during pregnancy, J. Clin. Pathol. 13: 353 (1960).
Stirling, J. L., Separation and characterisation of N-acetyl-β-glucosaminidases A and P from maternal serum, Biochim. Biophys. Acta 271: 154 (1972).
Lowden, J. A. and LaRamee, M. A., Problems in prenatal diagnosis using sphingolipid hydrolase assays, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 257–267 (1972).
Huddleston, J. F., Lee, G., and Robinson, J. C., Electrophoretic characterization of glucose dehydrogenase, β-glucuronidase, and N-acetyl-β-glucosaminidase from placenta and gestational serum, Am. J. Obstet. Gynecol. 109: 1017 (1971).
Hayase, K. and Kritchevsky, D., Separation and comparison of isoenzymes of N-acetyl-beta-D-hexosaminidase of pregnancy serum by Polyacrylamide gel electrofocusing, Clin. Chim. Acta 46: 455 (1973).
Hayase, K., Reisher, S. R., and Kritchevsky, D., Microheterogeneity of N-acetyl-β-D-hexosaminidase of bull epididymis, Proc. Soc. Exp. Biol. Med. 142: 466 (1973).
Williamson, A. R., Salaman, M. R., and Kreth, H. W., Microheterogeneity and allomorphism of proteins, Ann. N. Y. Acad. Sci. 209: 210 (1973).
Ikonne, J. U. and Ellis, R. B., N-Acetyl-β-D-hexosaminidase component A. Different forms in human tissues and fluids, Biochem. J. 135: 457 (1973).
Schneck, L., Friedland, J., Valenti, C., Adachi, M., Amsterdam, D., and Volk, B. W., Prenatal diagnosis of Tay-Sachs disease, Lancet 1: 582 (1970).
Murphy, J. V., Hexosaminidases in cell-free amniotic fluid, Life Sci. 11: 309 (1972).
Friedland, J., Schneck, L., Saifer, A., Pourfar, M., and Volk, B. W., Identification of Tay-Sachs disease carriers by acrylamide gel electrophoresis, Clin. Chim. Acta 28: 397 (1970).
Murphy, J. V. and Craig, L., Effect of human cerebral neuraminidase on hexosaminidase A, Clin. Chim. Acta 51: 67 (1974).
Leibovitz, Z. and Gatt, S., Enzymatic hydrolysis of sphingolipids. VII. Hydrolysis of gangliosides by a neuraminidase from calf brain, Biochim. Biophys. Acta 152: 136 (1968).
Tallman, J. F., Johnson, W. G., and Brady, R. O., The metabolism of Tay-Sachs ganglioside: Catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue, J. Clin. Invest. 51: 2339 (1972).
Tallman, J. F. and Brady, R. O., The catabolism of Tay-Sachs ganglioside in rat brain lysosomes, J. Biol. Chem. 247: 7570 (1972).
Sandhoff, K., The hydrolysis of Tay-Sachs ganglioside (TSG) by human N-acetyl-β-D-hexosaminidase A, FEBS Lett. 11: 342 (1970).
Sandhoff, K., Harzer, K., Wässle, W., and Jatzkewitz, H., Enzyme alterations and lipid storage in three variants of Tay-Sachs disease, J. Neurochem. 18: 2469 (1971).
Sandhoff, K. and Jatzkewitz, H., The chemical pathology of Tay-Sachs disease, in, Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 305–319 (1972).
Wenger, D. A., Okada, S., and O’Brien, J. S., Studies on the substrate specificity of hexosaminidase A and B from liver, Arch. Biochem. Biophys. 153: 116 (1972).
Brady, R. O., The sphingolipidoses, New Engl. J. Med. 275: 312 (1966).
Kolodny, E. H., Sandhoff’s disease: Studies on the enzyme defect in homozygotes and detection of heterozygotes, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 321–341 (1972).
Desnick, R. J., Snyder, P. D., Desnick, S. J., Krivit, W., and Sharp, H. L., Sandhoff’s disease: Ultrastructural and biochemical studies, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 351–371 (1972).
Tateson, R. and Bain, A. D., GM2 gangliosidoses: Consideration of the genetic defects, Lancet 2: 612 (1971).
Brady, R. O., Tallman, J. F., Johnson, W. G., and Quirk, J. M., An investigation of the metabolism of Tay-Sachs ganglioside specifically labeled in critical portions of the molecule, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 277–285 (1972).
Snyder, P. D., Jr., Krivit, W., and Sweeley, C. C., Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain, J. Lipid Res. 13: 128 (1972).
Suzuki, Y., Jacob, J. C., Suzuki, K., Kutty, K. M., and Suzuki, K., GM2-gangliosidosis with total hexosaminidase deficiency, Neurology 21: 313 (1971).
Yabuuchi, H., Sumi, K., Okada, S., and Yutaka, T., Chromatograpic study of serum hexosaminidase in normal and GM2-gangliosidosis, Clin. Chim. Acta 53: 85 (1974).
O’Brien, J. S., Okada, S., Ho, M. W., Fillerup, D. L., Veath, M. L., and Adams, K., Ganglioside storage diseases, Fed. Proc. Fed. Am. Soc. Exp. Biol. 30: 956 (1971).
Padeh, B. and Navon, R., Diagnosis of Tay-Sachs disease by hexosaminidase activity in leukocytes and amniotic cells, Israel J. Med. Sci. 7: 259 (1971).
Suzuki, Y., Berman, P. H., and Suzuki, K., Detection of Tay-Sachs disease heterozygotes by assay of hexosaminidase A in serum and leukocytes, J. Pediatr. 78: 643 (1971).
O’Brien, J. S., Ganglioside storage diseases, in: Advances in Human Genetics, H. Harris and K. Hirschhorn, eds., Plenum Press, New York, Vol. 3, pp. 39–98 (1972).
Navon, R., and Padeh, B., Urinary test for identification of Tay-Sachs genotypes, J. Pediatr. 80: 1026 (1972).
Carmody, P. J., Rattazzi, M. C., and Davidson, R. G., Tay-Sachs disease—The use of tears for the detection of heterozygotes, New Engl. J. Med. 289: 1072 (1973).
Kaback, M. M.: Thermal fractionation of serum hexosaminidases: Applications to heterozygote detection and diagnosis of Tay-Sachs disease, in: Methods of Enzymology, V. Ginsburg, ed., Academic Press, New York, Vol. 28, part B, pp. 862–867 (1973).
Saifer, A. and Rosenthal, A. L., Rapid test for the detection of Tay-Sachs disease heterozygotes and homozygotes by serum hexosaminidase assay, Clin. Chim. Acta 43: 417 (1973).
Rattazzi, M. C. and Davidson, R. G., Prenatal detection of Tay-Sachs disease, in: Antenatal Diagnosis, A. Dorfman, ed., University of Chicago Press, Chicago, 111., pp. 207–211 (1972).
Saifer, A. and Parkhurst, G. W., N-Acetyl-β-D-hexosaminidase isoenzyme pattern in Tay-Sachs disease, Clin. Chem. 20: 881 (1974) (Abstract 139).
Kaback, M. M. and Zeiger, R. S., Heterozygote detection in Tay-Sachs disease: A pro-totype community screening program for the prevention of recessive disorders, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 613–632 (1972).
Lowden, J. A., Skomorowski, M. A., Henderson, F., and Kaback, M., Automated assay of hexosaminidases in serum, Clin. Chem. 19: 1345 (1973).
Delvin, E., Pottier, A., Scriver, C. R., and Gold, R. J. M., The application of an automated hexosaminidase assay to genetic screening. Clin. Chim. Acta 53: 135 (1974).
Saifer, A. and Perle, G., Automated determination of serum hexosaminidase A by pH inactivation for detection of Tay-Sachs disease heterozygotes, Clin. Chem. 20: 538 (1974).
Saifer, A., Perle, G., Valenti, C., and Schneck, L., Pre- and postnatal detection of Tay-Sachs disease. A comparative study of biochemical screening methods, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 599–611 (1972).
Schneck, L., Adachi, M., and Volk, B. W., Chemical pathology of Tay-Sachs disease in the fetus, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 385–394 (1972).
Saifer, A., Schneck, L., Perle, G., Valenti, C., and Volk, B. W., Caveats of antenatal diagnosis of Tay-Sachs disease, Am. J. Obstet. Gynecol. 115: 553 (1973).
Friedland, J., Perle, G., Saifer, A., Schneck, L., and Volk, B. W., Screening for Tay-Sachs disease “in utero” using amniotic fluid, Proc. Soc. Exp. Biol. Med. 136: 1297 (1971).
Okada, S., Veath, M. L., and O’Brien, J. S., Juvenile GM2 gangliosidosis: Partial deficiency of hexosaminidase A, J. Pediatr. 77: 1063 (1970).
Suzuki, Y. and Suzuki, K., Partial deficiency of hexosaminidase component A in juvenile GM2-gangliosidosis, Neurology 20: 848 (1970).
Schneck, L., Friedland, J., Pourfar, M., Saifer, A., and Volk, B. W., Hexosaminidase activities in a case of systemic GM2 gangliosidosis of the late infantile type, Proc. Soc. Exp. Biol. Med. 133: 997 (1970).
Norman, R. N., Urich, H., Tingey, A. H., and Goodbody, R. A., Tay-Sachs disease with visceral involvement and its relationship to Niemann-Pick’s disease, J. Pathol. Bacteriol. 72: 409 (1959).
Taori, G. M., Basu, D. K., Chandi, S., Raman, P. T., Abraham, J., Leelavathy, R., and Job, C. K., GM1-gangliosidosis, J. Neurol. Sci. 21: 77 (1974).
Wolfe, L. S., Callahan, J., Fawcett, J. S., Andermann, F., and Scriver, C., GM1-gangliosidosis without chondrodystrophy or visceromegaly: β-Galactosidase deficiency with gangliosidosis and the excessive excretion of a keratan sulfate, Neurology 20: 23 (1970).
Suzuki, Y., Crocker, A. C., and Suzuki, K., GM1-gangliosidosis. Correlation of clinical and biochemical data, Arch. Neurol. (Chicago) 24: 58 (1971).
Okada, S. and O’Brien, J. S., Generalized gangliosidosis: β-Galactosidase deficiency, Science 160: 1002 (1968).
Sloan, H. R., Uhlendorf, B. W., Jacobson, C. B. and Fredrickson, D. S., β-Galactosidase in tissue culture derived from human skin and bone marrow: Enzyme defect in GM1-gangliosidosis, Pediatr. Res. 3: 532 (1969).
Dacremont, G. and Kint, J. A., GM1-ganglioside accumulation and β-galactosidase deficiency in a case of GM1-gangliosidosis (Landing disease), Clin. Chim. Acta 21: 421 (1968).
Van Hoof, F. and Hers, H. G., The abnormalities of lysosomal enzymes in mucopolysaccharidoses, Eur. J. Biochem. 7: 34 (1968).
MacBrinn, M. C., Okada, S., Ho, M. W., Hu, C. C., and O’Brien, J. S., Generalized gangliosidoses. Impaired cleavage of galactose from a mucopolysaccharide and a glycoprotein, Science 163: 946 (1969).
Brady, R. O., O’Brien, J. S., Bradley, R. M., and Gal, A. E., Sphingolipid hydrolases in brain tissue of patients with generalized gangliosidosis, Biochim. Biophys. Acta 210: 193 (1970).
Suzuki, Y. and Suzuki, K., Glycosphingolipid β-galactosidases. IV. Electrofocusing characterization in GM1-gangliosidosis, J. Biol. Chem. 249: 2113 (1974).
Singer, H. S. and Schafer, I. A., White cell β-galactosidase activity, New Engl. J. Med. 282: 571 (1970).
Thomas, G. H., β-D-Galactosidase in human urine: Deficiency in generalized gangliosidosis, J. Lab. Clin. Med. 74: 725 (1969).
Hultberg, B. and Ockerman, P. A., Artificial substrates in the assay of acid glycosidases, Clin. Chim. Acta 39: 49 (1972).
Suzuki, Y. and Suzuki, K., Glycosphingolipid β-galactosidases. I. Standard assay procedures and characterization by electrofocusing and gel filtration of the enzymes in normal human liver, J. Biol. Chem. 249: 2098 (1974).
Ho, M. W. and O’Brien, J. S., Stimulation of acid β-galactosidase activity by chloride ions, Clin. Chim. Acta 30: 531 (1970).
Ho, M. W. and O’Brien, J. S., Hurler’s syndrome: Deficiency of a specific beta-galactosidase isoenzyme, Science 165: 611 (1969).
Pinsky, L., Powell, E., and Callahan, J., GM1-gangliosidosis types 1 and 2: Enzymatic differences in cultured fibroblasts, Nature (London) 228: 1093 (1970).
Ho, M. W. and O’Brien, J. S., Differential effect of chloride ions on β-galactosidase isoenzymes: A method for separate assay, Clin. Chim. Acta 32: 443 (1971).
O’Brien, J. S., Five gangliosidoses, Lancet 2: 805 (1969).
Hultberg, B., Ockerman, P.-A., and Dahlqvist, A., Gargoylism: Hydrolysis of β-galactosides and tissue accumulation of galactose- and mannose-containing compounds, J. Clin. Invest. 49: 216 (1970).
Singer, H. S. and Schafer, I. A., Clinical and enzymatic variations in GM1 generalized gangliosidosis, Am. J. Hum. Genet. 24: 454 (1972).
Navon, R., Padeh, B., and Adam, A., Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am. J. Hum. Genet. 25: 287 (1973).
Tallman, J. F., Brady, R. O., Quirk, J. M., Villalba, M., and Gal, A. E., Isolation and relationship of human hexosaminidases, J. Biol. Chem. 249: 3489 (1974).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Saifer, A. (1975). Enzymes. In: Volk, B.W., Schneck, L. (eds) The Gangliosidoses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8726-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-8726-2_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-8728-6
Online ISBN: 978-1-4615-8726-2
eBook Packages: Springer Book Archive